Table 1.
Accuracies per cancer
| Cancer | Total correct | Total samples | Percent correct | Sensitivity | Specificity |
|---|---|---|---|---|---|
| Bladder cancer | 7 | 11 | 63.6% | 64% | 100% |
| Breast cancer | 11 | 11 | 100% | 100% | 99% |
| Colorectal cancer | 5 | 9 | 55.6% | 54% | 99% |
| Gastric cancer | 10 | 15 | 66.7% | 67% | 98% |
| Liver cancer | 6 | 8 | 75.0% | 75% | 100% |
| Lung cancer | 14 | 15 | 93.3% | 93% | 95% |
| Lymphoma | 23 | 25 | 92.0% | 88% | 99% |
| Melanoma | 15 | 17 | 88.2% | 88% | 99% |
| Ovarian cancer | 7 | 9 | 77.8% | 78% | 98% |
| Pancreatic cancer | 4 | 13 | 30.8% | 23% | 99% |
| Prostate cancer | 10 | 11 | 90.9% | 91% | 100% |
| Renal cancer | 10 | 11 | 90.9% | 91% | 100% |
| Sarcoma | 5 | 7 | 71.4% | 71% | 97% |
| Testicular cancer | 13 | 16 | 81.3% | 81% | 100% |
| Thyroid cancer | 6 | 9 | 66.7% | 67% | 100% |
| Total/average | 146 | 187 | 78.1% | 72% | 99% |
Numbers given for each cancer type are all samples correctly classified, all samples tested, the percentage of samples correctly classified as well as the sensitivity and specificity of the tissue of origin identification.